The studies performed in the frame of a project destined for the search of new (t,n) and (p,n) reactions of interest in nuclear reactors are described. Experimental evidences of the observations of the reactions: 46 Ti(t,n) 48 V, 48 Ti(p,n) 48 V, 52 Cr(t,n) 54 Mn, 56 Fe(p,n) 56 Co, 72 Ge(t,n) 74 As and 74 Ge(p,n) 74 As, are presented. Additional data on some secondary reactions, already characterised for the production of 7 Be, 56 Co, 58 Co, 65 Zn and 88 Y, were also obtained. The significance of these data is discussed.
The comparative advantages and drawbacks of some reactor-produced arsenic radioisotopes having favourable characteristics for their use as tracers are discussed. The study comprises their preparation based on: (a) capture reactions on germanium; (b) threshold reactions on germanium, selenium and bromine; (c) secondary reactions on germanium, induced by recoil protons and tritons produced by the action of neutrons on lithium. The recommended options for the production of relatively short half-life radionuclides are 77 As by capture on germanium or 76 As via (n,α) reaction on bromine, while two different ways are applicable for the production of 74 As, longer-lived radioisotope.
The production of 48 V in a nuclear reactor, induced on titanium by tritons generated from the 6 Li(n, t) 4 He reaction, and eventually 7 Li(n, n t) 4 He, is described. Samples of lithium titanate were irradiated for an irradiation cycle (120 h) in the RA-3 reactor, belonging to Ezeiza Atomic Centre. After a radiochemical separation, the characteristic radiations from 48 V were identified in the gamma ray spectra of the vanadium fractions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.